{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T19:31:02Z","timestamp":1784921462542,"version":"3.55.0"},"reference-count":27,"publisher":"The Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,8,1]]},"DOI":"10.1210\/jc.2010-0167","type":"journal-article","created":{"date-parts":[[2010,5,20]],"date-time":"2010-05-20T02:12:47Z","timestamp":1274321567000},"page":"3641-3647","source":"Crossref","is-referenced-by-count":94,"title":["Treatment of Type B Insulin Resistance: A Novel Approach to Reduce Insulin Receptor Autoantibodies"],"prefix":"10.1210","volume":"95","author":[{"given":"R.","family":"Malek","sequence":"first","affiliation":[{"name":"Clinical Endocrine Branch (R.M., A.Y.C., B.C.L., A.O.L., E.K.C., P.G.) National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Y.","family":"Chong","sequence":"additional","affiliation":[{"name":"Clinical Endocrine Branch (R.M., A.Y.C., B.C.L., A.O.L., E.K.C., P.G.) National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. C.","family":"Lupsa","sequence":"additional","affiliation":[{"name":"Clinical Endocrine Branch (R.M., A.Y.C., B.C.L., A.O.L., E.K.C., P.G.) National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. O.","family":"Lungu","sequence":"additional","affiliation":[{"name":"Clinical Endocrine Branch (R.M., A.Y.C., B.C.L., A.O.L., E.K.C., P.G.) National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. K.","family":"Cochran","sequence":"additional","affiliation":[{"name":"Clinical Endocrine Branch (R.M., A.Y.C., B.C.L., A.O.L., E.K.C., P.G.) National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Soos","sequence":"additional","affiliation":[{"name":"Metabolic Research Laboratories (M.A.S., R.K.S.), Institute of Metabolic Science, University of Cambridge, Addenbrooke\u2019s Hospital, Cambridge CB2 0QQ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. K.","family":"Semple","sequence":"additional","affiliation":[{"name":"Metabolic Research Laboratories (M.A.S., R.K.S.), Institute of Metabolic Science, University of Cambridge, Addenbrooke\u2019s Hospital, Cambridge CB2 0QQ, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. E.","family":"Balow","sequence":"additional","affiliation":[{"name":"Kidney Diseases Branch (J.E.B.), National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Gorden","sequence":"additional","affiliation":[{"name":"Clinical Endocrine Branch (R.M., A.Y.C., B.C.L., A.O.L., E.K.C., P.G.) National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041114004627800_R1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00005792-200203000-00001","article-title":"Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance): a 28-year perspective.","volume":"81","author":"Arioglu","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"key\n\t\t\t\t2019041114004627800_R2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0140-6736(87)90063-8","article-title":"Autoimmunity to insulin receptor and hypoglycaemia in patient with Hodgkin\u2019s disease.","volume":"1","author":"Braund","year":"1987","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041114004627800_R3","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-2141.1990.tb06381.x","article-title":"Hypoglycaemia and Hodgkin\u2019s disease.","volume":"76","author":"Chan","year":"1990","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t2019041114004627800_R4","first-page":"123","article-title":"Autoimmune mechanisms of insulin resistance and hypoglycemia","author":"Gorden","year":"1993","journal-title":"In: Moley DE, ed. Insulin resistance. London: John Wiley;"},{"key":"key\n\t\t\t\t2019041114004627800_R5","first-page":"1242","article-title":"Low molecular weight follicle-stimulating hormone receptor binding inhibitor in sera from premature ovarian failure patients.","volume":"74","author":"Sluss","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114004627800_R6","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1210\/jc.2008-1749","article-title":"Anti-melanocortin-4 receptor autoantibodies in obesity.","volume":"94","author":"Peter","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114004627800_R7","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1172\/JCI108600","article-title":"Characterization of antibodies to the insulin receptor: a cause of insulin-resistant diabetes in man.","volume":"58","author":"Flier","year":"1976","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041114004627800_R8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1126\/science.170678","article-title":"Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance.","volume":"190","author":"Flier","year":"1975","journal-title":"Science"},{"key":"key\n\t\t\t\t2019041114004627800_R9","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1056\/NEJM197604012941401","article-title":"The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man.","volume":"294","author":"Kahn","year":"1976","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041114004627800_R10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2337\/diab.33.3.301","article-title":"Characterization of the serum from a patient with insulin resistance and hypoglycemia. Evidence for multiple populations of insulin receptor antibodies with different receptor binding and insulin-mimicking activities.","volume":"33","author":"De Pirro","year":"1984","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041114004627800_R11","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1210\/jcem-73-3-650","article-title":"Insulin resistance and hypoglycemia in a patient with systemic lupus erythematosus: description of antiinsulin receptor antibodies that enhance insulin binding and inhibit insulin action.","volume":"73","author":"Di Paolo","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114004627800_R12","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum.","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114004627800_R13","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1210\/jc.2006-0166","article-title":"Elevated plasma adiponectin in humans with genetically defective insulin receptors.","volume":"91","author":"Semple","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114004627800_R14","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1464-5491.2005.01529.x","article-title":"Successful treatment of type B insulin resistance in a patient with otherwise quiescent systemic lupus erythematosus.","volume":"22","author":"Coll","year":"2005","journal-title":"Diabet Med"},{"key":"key\n\t\t\t\t2019041114004627800_R15","first-page":"315","article-title":"Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis.","volume":"119","author":"Semple","year":"2009","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041114004627800_R16","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.2337\/db06-1665","article-title":"Paradoxical elevation of high-molecular weight adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies.","volume":"56","author":"Semple","year":"2007","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041114004627800_R17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(02)09335-2","article-title":"Adiponectin and development of type 2 diabetes in the Pima Indian population.","volume":"360","author":"Lindsay","year":"2002","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041114004627800_R18","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis.","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041114004627800_R19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4158\/EP.13.1.51","article-title":"Type B insulin resistance syndrome associated with systemic lupus erythematosus.","volume":"13","author":"Bao","year":"2007","journal-title":"Endocr Pract"},{"key":"key\n\t\t\t\t2019041114004627800_R20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1210\/jcem-68-1-227","article-title":"Atypical antiinsulin receptor antibodies in a patient with type B insulin resistance and scleroderma.","volume":"68","author":"Bloise","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114004627800_R21","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2337\/diacare.21.8.1217","article-title":"Successful treatment with plasmapheresis, cyclophosphamide, and cyclosporin A in type B syndrome of insulin resistance. Case report.","volume":"21","author":"Eriksson","year":"1998","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t2019041114004627800_R22","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/art.10879","article-title":"Treatment of systemic lupus erythematosus-associated type B insulin resistance syndrome with cyclophosphamide and mycophenolate mofetil.","volume":"48","author":"Gehi","year":"2003","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t2019041114004627800_R23","first-page":"816","article-title":"Refractory hyperglycemia complicating an evolving connective tissue disease: response to cyclosporine.","volume":"25","author":"Kramer","year":"1998","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t2019041114004627800_R24","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ncpendmet0693","article-title":"A patient with type B insulin resistance syndrome, responsive to immune therapy.","volume":"3","author":"Page","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041114004627800_R25","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/00007611-198707000-00023","article-title":"Successful immunosuppressive therapy in a patient with autoantibodies to insulin receptors and immune complex glomerulonephritis.","volume":"80","author":"Sims","year":"1987","journal-title":"South Med J"},{"key":"key\n\t\t\t\t2019041114004627800_R26","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5694\/j.1326-5377.2009.tb02335.x","article-title":"Treatment of type B insulin resistance with immunoglobulin: novel use of an old therapy","volume":"190","author":"Tran","year":"2009","journal-title":"Med J Aust"},{"key":"key\n\t\t\t\t2019041114004627800_R27","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJM200401153500324","article-title":"Rituximab therapy for the type B syndrome of severe insulin resistance.","volume":"350","author":"Coll","year":"2004","journal-title":"N Engl J Med"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/95\/8\/3641\/9066844\/jcem3641.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T21:37:22Z","timestamp":1591306642000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/95\/8\/3641\/2596531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,1]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2010-0167","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,1]]}}}